Introduction: In Burkina Faso, the tuberculosis (TB) treatment failure rate increased from 2.5% in 2000 to 8.3% in 2006. The risk factors for TB
Introduction
In Burkina Faso, the incidence of TB, all forms, increased from patients who failed to TB-treatment is not high, the treatment failure rate is an important problem because of the possibility that these patients could harbor resistant Mycobacterium tuberculosis bacilli. The treatment failure is a health and economic burden as the patient remains a source of infection in the community and it may lead to the development of multidrug resistance, apart from the indirect economic burden attributed to absence from work and inability to work. There is very limited information on factors leading to TB treatment failure in Burkina Faso. Knowledge of factors associated with TB treatment failure could assist healthcare workers in identifying the particular personal stressors that inhibit compliance with TB treatment, as well as provider-level impediments to achieving treatment completion. This study aims to identify these factors associated with TB treatment failure in four health regions where treatment failure is reported. It is anticipated that the findings of this investigation will be used to develop an intervention site that will pilot the use of innovative case management approaches to reduce TB treatment failure rate, ensure treatment completion among pulmonary TB patients and prevent TB multidrug resistance.
Possible reasons for treatment failure in patients receiving appropriate regimens include [4, 5] : non adherence to the drug regimen, drug resistance, malabsorption of drugs, laboratory error, and extreme biological variation in response. In Finland a cohort study of risk factors for poor TB treatment outcome found that the significant risk factors included: male sex, older age, non-HIV related immunosuppression, previous history of TB, and pause in treatment [6] . In Brazil, researchers found that treatment delay, previous TB treatment, lifestyle factors, illiteracy and excessive alcohol consumption, and not having received family support were associated with treatment failure [7] . In Cameroon, a study report that age above or equal to 40 years and bacillary of 3+ or pretreatment sputum smear were significantly associated with non conversion of sputum smear at the end of two months of treatment.
Also persistent positive smear at the end of two months of treatment were significantly associated with unfavorable treatment outcomes [8] . An earlier case-control study in Egypt aiming at investigating predictors of treatment failure found that noncompliance to treatment, deficient health education to the patient, poor patient knowledge regarding the disease and diabetes mellitus as co-morbid condition were significant risk factors [9] . In Nigeria, a cohort of sputum smear-positive pulmonary tuberculosis patients at the initiation of therapy who were followed up to the end of treatment at eighth month reported that male gender and poor knowledge of tuberculosis predicted poor treatment outcome [10] .
In Burkina Faso, a study conducted in the referral TB Centre (National Tuberculosis Centre in Ouagadougou) with 110 patients that had experienced failure, relapse, and treatment abandonment for at least 1 month observed a prevalence of 67.4% M.Tuberculosis drug resistance [11] . When studying risk factors for Multidrug-Resistant (MDR) TB in four centres in Burkina Faso, TB known contact, previous treatment, were risk factors significantly associated with MDR-TB [12] . The study objectives were: to determine the factors associated with TB treatment failure among pulmonary TB patients in four health regions in Burkina Faso, 2009; to recommend intervention project based on identified factors associated in order to reduce TB treatment failure.
Methods
Pulmonary TB is defined as having two or more positive sputum smear examinations for Acid-Fast Bacilli; cured: patient who had completed full anti-TB treatment and was sputum smear negative after 5 months of treatment; treatment failure: sputum smear remained or became positive after 5 months of anti-TB treatment after treatment initiation; treatment delay: time interval between TB diagnosis and initiation of anti-TB drugs is more than 14 days; failure to take TB drug: who failed to take TB drug for 14 days or more; failure to collect TB drugs from health center: were considered failure to collect TB drug from health center when the medicine had been stock of out; having underlying condition:
patients who declared having chronic condition such as liver disease, kidney disease, HIV/aids; having family member who take care: patients who have a family member who help him to feed, transport and remind him to take his TB drug. The North, North- For stratified analysis we performed the following steps: we performed crude analysis by calculating crude OR for each factor with confidence interval and p-value; we stratified the data by potential confounders and effect modifiers (age group and sex). we calculated stratum-specific OR; age group < 45 years and 45 years and older were considered; cut off 45 years was chosen to be able to compare with other studies; we evaluated for effect modification by comparing stratum-specific OR; If effect modification is present (stratum-specific OR differ from one another), we stopped and reported stratum-specific OR; If effect modification is absent 
Results
The majority of patients (60%) were from North health region.
Median age was 39.5 years (ranged 18-77 years) for cases and 38.5 years (ranged 18-82 years) for controls. As show in Table 1 , cases and controls were comparable for age except age group of less than 25 years. Cases had more male when controls had almost the same between male and female. Cases and controls were also comparable for marital status, education level and occupation.
Bivariate analysis
In Bivariate analysis, in Table 2 , sex was significantly associated with TB treatment failure. Cases were two times more likely to be male (p=0.006) than controls. Being less than 45 years old is protective. However it is not statistically significant. 
Patient related factors

Stratify analysis
Factors associated with TB treatment failure were stratified by age group and sex to assess for possible confounding and effect modification (seeTable 5, Table 6 ). Table 6 shows that among TB treatment failure, males were three times more likely to have sputum smear-positive after 2 months of treatment than females. The sex appears to be effect modifier. Also, males were eight times more likely to fail to take TB drugs than
Age as effect modifier
Sex as effect modifier
females. Age appears to interact with sputum smear result after 2 months of treatment, existence of underlying condition, history of previous TB treatment, failure to visit TB centre to get TB drug centre and the sex interacts with laboratory result positive after 2 month of treatment and fail to take TB drug.
Multivariable analysis
Multivariable logistic regression analysis was performed to study the factors associated with TB treatment failure while controlling other possible factor associated ( Table 7) . Those independent factors, Studies from China and from Thailand also reported relationship between a positive sputum examination at two months and treatment failure [18, 19] . Munoz in Ethiopia and Singla in India reported similar findings [20, 21] . These patients will require more In our study, cases were 18 times more likely to fail to take their TB medication. This odd is 8 times higher in males. Among cases, the most common reason for failing to take TB drugs, was that side effects were either too common or too much to deal with. Other reasons for failure to take TB drug were travelling trips, closure of health facilities during strikes and absence of health care workers to provide TB drugs. Our findings are similar to Morsy's in Egypt who reported that 8 missed doses are associated with an increase in the risk of treatment failure [9] . This case control study highlights the factors associated with TB treatment failure. These factors are:
patients who failed to take TB drugs, patients who had underlying condition such as liver and kidney disease, patients who used traditional medicines or herbs, and patient who still have sputum smear positive after 2 months of treatment. Previous treatment guidelines have recommended that if the smear is positive after 2 months of treatment, continue the initial phase for an extra month before proceeding with the standard 4-month continuation phase. It is designed for low-resources settings that lack the ability to do culture or drug-susceptibility testing. These recommendations have been questioned in our study and in other studies [16] [17] [18] [19] [20] [21] , as the extra month of treatment before proceeding with the standard 4-month continuation phase does not guaranty treatment success at the end of the 6 month treatment. More studies need to be done to assess this recommendation. Moreover, the national referral laboratory capacity to do drug susceptibility testing and routine therapeutic drug monitoring earlier in case of non conversion after 2 months of treatment is very crucial.
Our study has some limitations: the time-lag between the TB treatment failure and the interview was around one year and might result in a recall bias. Also the interviews were conducted by health workers in TB diagnosis and treatment centres who knows previously the patients and this will lead that participants respond to particular questions with the answers that they consider to be most socially desirable (or least stigmatizing), rather than answering with complete honesty. The factors related to health care services were not investigated and may play a role in TB treatment failure.
Conclusion
The independent risk factors for TB treatment failure identified are failing to take TB drugs for more than 14 days, having underlying diseases such as liver and kidney disease, usage of traditional medicines or herbs, and having sputum smear positive after 2 months of treatment. Factors related to health care services were not investigated and may also play a role in TB treatment failure.
There is thus need to study health centre-specific challenges to high TB treatment success rate in our environment. 
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